Vnitr Lek 2009, 55(4):403-407

Drug-drug interactions in diabetic patients at the department of clinical pharmacology

L. Magulová1,*, T. Foltánová2
1 Oddelenie klinickej farmakológie Fakultnej nemocnice Nitra, Slovenská republika, vedúci pracoviska PharmDr. Lívia Magulová, Ph.D.
2 Katedra farmakológie a toxikológie liečiv Farmaceutické fakulty UK Bratislava, Slovenská republika, prednosta prof. PharmDr. Ján Kyselovič, CSc.

Drug-drug interactions in diabetic patients could be serious, even life threatening. Possible manifestation of hypo/hyperglycemia as a consequence of drug-drug interactions are often wrong interpreted as a nonadherence to the diabetic diet or polymorbidity of the patient. Drug-drug interactions are not taken into account. The risk of drug-drug interactions is exponentially increasing with the number of taken drugs. In the group of diabetic patients is good to prevent the combinations of drugs, which can lead to drug-drug interactions and use alternative therapy with lower potential of drug-drug interactions. In this paper we present the possibilities of clinical pharmacist from the Department of clinical pharmacology to prevent and solve the drug-drug interactions in diabetic patients.

Keywords: drug-drug interactions; diabetic patients; alternative combinations

Received: February 2, 2009; Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Magulová L, Foltánová T. Drug-drug interactions in diabetic patients at the department of clinical pharmacology. Vnitr Lek. 2009;55(4):403-407.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Baxter K. Stockley's Drug Interactions. 7th ed. London: Pharmaceutical Press 2006: 917-958.
    2. Tatro DS. Drug interaction facts. St. Louis: Wolters Kluwer Health 2008.
    3. Magulová L, Božeková L, Kriška M et al. Interakcie liečiv v klinickej praxi. 2. vyd. Bratislava: SAP 2004.
    4. Walker R, Edwards C. Clinical Pharmacy and Therapeutics. 2th ed. Edinburgh: Churchill Livingstone 1999.
    5. Katzung BG. Základní a klinická farmakologie. 2. vyd. Praha: H&H Vyšehradská 2006: 1070-1081.
    6. Ďurišová A. Interakcie liečiv u detí. Čes Slov Pediat 2005; 60: 428-432.
    7. Khamaisi M, Leitersdorf E. Severe hypoglycemia from clarithromycin-repaglinide drug interaction. Pharmacotherapy 2008; 28: 682-684. Go to original source... Go to PubMed...
    8. Šmahelová A. Metformin a ledviny. Vnitř Lék 2008; 54: 535-540. Go to PubMed...
    9. Arnold JM, Yusuf S, Young J et al. HOPE Investigators. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003; 107: 1284-1290. Go to original source... Go to PubMed...
    10. Magula D, Dvořák F, Ondrisová Z. Miesto klinickej biochémie v monitorovaní nežiaducich účinkov farmakoterapie. Lab diagnostika 2000; 5: 64-65.
    11. Wawruch M, Fialová D, Žikavská M et al. Používanie potenciálne nevhodných liečiv pre starších pacientov v regióne Česko-Slovenska. Klin Farmakol Farm 2008; 22: 108-110.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.